Biotron (ASX:BIT) ROE % Adjusted to Book Value : -2.17% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Biotron ROE % Adjusted to Book Value?

Biotron's ROE % for the quarter that ended in Dec. 2023 was -105.04%. Biotron's PB Ratio for the quarter that ended in Dec. 2023 was 48.50. Biotron's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -2.17%.

Biotron ROE % Adjusted to Book Value Historical Data

The historical data trend for Biotron's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotron ROE % Adjusted to Book Value Chart

Biotron Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-8.04

-6.48

-3.80

-25.20

Biotron Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-3.77	-13.49	-18.36	-2.17	-

Competitive Comparison of Biotron's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Biotron's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotron's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotron's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biotron's ROE % Adjusted to Book Value falls into.

Biotron ROE % Adjusted to Book Value Calculation

Biotron's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-234.69%	/	N/A
	=	N/A

Biotron's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-105.04%	/	48.50
	=	-2.17%

Biotron ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biotron's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotron Ltd (ASX:BIT) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

BITRF:USA

Address

56 Delhi Road, Suite 3.3, North Ryde, Sydney, NSW, AUS, 2113

Website

https://www.biotron.com.au

Biotron Ltd is a biotechnology company. It is engaged in the funding and management of intermediate and applied biotechnology research and development projects. Its antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of HIV-1 and hepatitis C virus infections. Geographically, it operates only in Australia through biotechnology segment.

Biotron Headlines

From GuruFocus

BlackRock Multi-Sector Income Trust's Dividend Analysis

By GuruFocus Research • 10-13-2023

BlackRock Announces Fiscal Year End Change for BlackRock Multi-Sector Income Trust (BIT)

By Business Wire Business Wire • 06-01-2023